Norén Åsa, Boi Roberto, Pullerits Rille, Mölne Johan, Ebefors Kerstin, Friman Styrbjörn, Sihlbom Carina, Herlenius Gustaf, Nyström Jenny, Oltean Mihai
The Transplant Institute, Sahlgrenska University Hospital, 413 45, Gothenburg, Sweden.
Institute of Clinical Sciences, Department of Surgery, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
J Transl Med. 2025 Jun 16;23(1):658. doi: 10.1186/s12967-025-06695-w.
Acute kidney injury (AKI) is a frequent complication after liver transplantation (LT) and is associated with morbidity, mortality, and late development of chronic kidney disease. Risk factors for AKI after LT include patient, perioperative and graft-related factors. The exact renal molecular mechanisms behind AKI in LT are unclear.
Alterations in the proteome were investigated in kidney biopsies from 21 patients undergoing LT using quantitative proteomics. The most upregulated protein was validated using immunohistochemistry. In addition, serum levels of interleukin (IL)-33, insulin-like growth factor binding protein (IGFBP)-7 and high-mobility group box (HMGB)-1 were analyzed. In silico data validation was performed using 14 recently published proteomics and transcriptomics datasets.
In post-reperfusion biopsies, we identified 731 differentially regulated proteins between patients with and without AKI. The most upregulated pathways were related to inflammation, integrin signaling and extracellular matrix (ECM) remodeling. The most downregulated pathways were traceable to a mitochondrial origin. HMGB-1 was found to be already upregulated (15%) 2 h after LT in patients who later developed AKI. The AKI group also showed upregulation of the alarmin IGFBP-7, caspases 1, 4 and 8, nuclear factor kappa B subunits, and the inflammasome adaptor protein PYCARD. Circulating IL-33 and HMGB-1 (but not IGFBP-7) increased during LT but returned to normal levels within 24 h. Altogether, these findings indicate ongoing inflammatory signaling activity in the kidneys of LT recipients who ultimately develop moderate or severe AKI shortly after liver graft reperfusion.
LT induces extensive alarmin signaling and ECM remodeling in the kidneys of recipients who develop postoperative AKI. Further strategies to curtail this phenomenon are mandated. Trial registration https://www.researchweb.org/is/en/vgr/project/278585 , Registered 24 May 2022 (Retrospectively registered).
急性肾损伤(AKI)是肝移植(LT)后常见的并发症,与发病率、死亡率以及慢性肾脏病的晚期发展相关。LT后AKI的危险因素包括患者因素、围手术期因素和移植物相关因素。LT中AKI背后的确切肾脏分子机制尚不清楚。
采用定量蛋白质组学研究了21例接受LT患者的肾活检组织中的蛋白质组变化。使用免疫组织化学对上调最明显的蛋白质进行了验证。此外,分析了白细胞介素(IL)-33、胰岛素样生长因子结合蛋白(IGFBP)-7和高迁移率族蛋白盒(HMGB)-1的血清水平。使用14个最近发表的蛋白质组学和转录组学数据集进行了计算机数据验证。
在再灌注后活检中,我们在有和没有AKI的患者之间鉴定出731种差异调节蛋白。上调最明显的通路与炎症、整合素信号传导和细胞外基质(ECM)重塑有关。下调最明显的通路可追溯到线粒体起源。在后来发生AKI的患者中,发现HMGB-1在LT后2小时已经上调(15%)。AKI组还显示警报素IGFBP-7、半胱天冬酶1、4和8、核因子κB亚基以及炎性小体衔接蛋白PYCARD上调。循环中的IL-33和HMGB-1(但不包括IGFBP-7)在LT期间升高,但在24小时内恢复到正常水平。总之,这些发现表明,在肝移植再灌注后不久最终发生中度或重度AKI的LT受者的肾脏中存在持续的炎症信号活动。
LT在发生术后AKI的受者肾脏中诱导广泛的警报素信号传导和ECM重塑。必须采取进一步策略来减少这种现象。试验注册https://www.researchweb.org/is/en/vgr/project/278585 ,2022年5月24日注册(回顾性注册)。